跳至主要内容
临床试验/NCT01403740
NCT01403740Unknown不适用

Observational Acquired Haemophilia Registry

Turkish Society of Hematology1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2011年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
250
试验地点
1

研究概览

简要总结

Turkish Acquired Haemophilia Registry is a database in which information about clinical features and therapeutic management of acquired haemophilia is collected in Turkey.This is a multicentre, retrospective and prospective registry of subjects diagnosed and/or treated for acquired haemophilia. Patients will be registered and the response to different therapies, details of each bleeding episode and the outcome of haemostatic and immunosuppressive therapy (IST) will be recorded. Any male or female subject diagnosed with inhibitors to FVIII or other factors and treated for acquired haemophilia can be entered on the registry. Patients will be treated according to local practice. No additional tests or procedures are required by the registry. The retrospective period will not be time-limited and data will be collected from those recorded in the hospital notes. The prospective period will begin in September 1.2011, and will last for two years.

研究设计

研究类型
Observational

入排标准

性别
All
接受健康志愿者

入选标准

  • Acquired haemophilia diagnosis, written consent

排除标准

  • Being unable to give written consent

研究组 & 干预措施

Acquired haemophilia patients

干预措施: rFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin (Drug)

研究者

发起方
Turkish Society of Hematology
申办方类型
Other

研究点 (1)

Loading locations...

相似试验